Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.95K Buy
1,447
+174
+14% +$843 ﹤0.01% 598
2025
Q4
$8.46K Sell
1,273
-119
-9% -$806 ﹤0.01% 591
2025
Q3
$8.55K Sell
1,392
-229
-14% -$1.79K ﹤0.01% 567
2025
Q2
$14.9K Hold
1,621
﹤0.01% 527
2025
Q1
$19.5K Buy
1,621
+291
+22% +$3.81K ﹤0.01% 505
2024
Q4
$14.7K Buy
+1,330
New +$18.7K ﹤0.01% 501

Other funds holding EOLS

GF Fund Management's EOLS Position: Q1 2026 in Review

GF Fund Management increased its Evolus (EOLS) stake by 14% in Q1 2026, buying an estimated $843 and bringing the position to 1,447 shares worth $5.95K. The position accounts for ﹤0.01% of the portfolio, ranked #598.

GF Fund Management first reported a position in EOLS in Q4 2024 and has held it in 6 quarters since. The position peaked at $19.5K in Q1 2025. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • GF Fund Management held 1,447 shares of Evolus worth $5.95K as of Q1 2026.
  • GF Fund Management bought 174 Evolus shares in Q1 2026, an estimated $843.
  • Evolus made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #598 holding.
  • GF Fund Management first reported a position in Evolus in Q4 2024 and has held it in 6 quarters since.
  • GF Fund Management's Evolus position peaked at $19.5K in Q1 2025.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.